• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对高效抗逆转录病毒疗法的免疫和病毒学反应不一致与死亡率增加及治疗依从性差有关。

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.

作者信息

Moore David M, Hogg Robert S, Yip Benita, Wood Evan, Tyndall Mark, Braitstein Paula, Montaner Julio S G

机构信息

British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6.

出版信息

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):288-93. doi: 10.1097/01.qai.0000182847.38098.d1.

DOI:10.1097/01.qai.0000182847.38098.d1
PMID:16249702
Abstract

OBJECTIVE

To examine the independent association of discordant virologic and immunologic responses to highly active antiretroviral therapy (HAART) with mortality.

METHODS

A population-based study of 1527 treatment-naive individuals initiating HAART used Cox proportional hazards modeling to determine the independent association of treatment response at 3 to 9 months with nonaccidental mortality. Logistic regression was used to examine associations with discordant responses.

RESULTS

Viral load (VL)/CD4 discordant responses were seen in 235 (15.4%) of subjects, and VL/CD4 responses were seen in 179 (11.7%) of subjects. In adjusted Cox regression models, discordant responses were found to be independently associated with an increased risk of mortality (VL/CD4: relative hazard [RH] = 1.87, 95% confidence interval [CI]: 1.15 to 3.04; VL/CD4: RH = 2.47, 95% CI: 1.54 to 3.95). VL/CD4 discordance was found to be associated with increasing age, baseline HIV RNA load <100,000 copies/mL, baseline CD4 counts <50 cells/muL, the use of lamivudine (3TC)/zidovudine (ZDV), and poor adherence to therapy. VL/CD4 discordance was associated with younger age; injection drug use; baseline HIV RNA load >100,000 copies/mL; the use of 3TC/ZDV, didanosine (ddI)/3TC, or ddI/stavudine; and poor adherence to therapy.

CONCLUSION

Discordant responses are independently associated with an increased risk of mortality and are, in turn, associated with poor adherence to therapy.

摘要

目的

探讨高效抗逆转录病毒治疗(HAART)中病毒学和免疫学反应不一致与死亡率之间的独立关联。

方法

一项基于人群的研究,对1527例初治并开始接受HAART的个体,采用Cox比例风险模型来确定3至9个月时治疗反应与非意外死亡率之间的独立关联。采用逻辑回归分析不一致反应的相关性。

结果

235例(15.4%)受试者出现病毒载量(VL)/CD4反应不一致,179例(11.7%)受试者出现VL/CD4反应一致。在调整后的Cox回归模型中,发现不一致反应与死亡风险增加独立相关(VL/CD4:相对风险[RH]=1.87,95%置信区间[CI]:1.15至3.04;VL/CD4:RH=2.47,95%CI:1.54至3.95)。发现VL/CD4不一致与年龄增加、基线HIV RNA载量<100,000拷贝/mL、基线CD4计数<50个细胞/μL、使用拉米夫定(3TC)/齐多夫定(ZDV)以及治疗依从性差有关。VL/CD4不一致与年龄较小、注射吸毒、基线HIV RNA载量>100,000拷贝/mL、使用3TC/ZDV、去羟肌苷(ddI)/3TC或ddI/司他夫定以及治疗依从性差有关。

结论

不一致反应与死亡风险增加独立相关,反过来又与治疗依从性差有关。

相似文献

1
Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.对高效抗逆转录病毒疗法的免疫和病毒学反应不一致与死亡率增加及治疗依从性差有关。
J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):288-93. doi: 10.1097/01.qai.0000182847.38098.d1.
2
Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy.对高效抗逆转录病毒疗法呈现免疫和病毒学反应不一致的初治HIV感染患者的临床结局
J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):553-8. doi: 10.1097/QAI.0b013e31816856c5.
3
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).司他夫定、去羟肌苷和茚地那韦与齐多夫定、拉米夫定和茚地那韦用于初始治疗HIV-1感染个体的比较:胸苷类似物方案疗法的选择(START II)
AIDS. 2000 Jul 28;14(11):1601-10. doi: 10.1097/00002030-200007280-00016.
4
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.一项随机、开放标签的比较三种高效抗逆转录病毒治疗方案(包括两种核苷类似物和茚地那韦)用于既往未接受治疗的HIV-1感染患者的研究:OzCombo1研究。
AIDS. 2000 Jun 16;14(9):1171-80. doi: 10.1097/00002030-200006160-00014.
5
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.初治HIV感染者中依从性对长期治疗反应的差异影响。
AIDS. 2008 Nov 12;22(17):2371-80. doi: 10.1097/QAD.0b013e328315cdd3.
6
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.泰国HIV感染人群中双核苷疗法与三核苷疗法的三年疗效
J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):693-701. doi: 10.1097/00126334-200406010-00006.
7
Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.2003 - 2006年,科特迪瓦,预防1型艾滋病毒母婴传播后母亲接受抗逆转录病毒治疗的12个月反应情况
Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.
8
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.同伴支持对接受抗逆转录病毒治疗的HIV感染患者病毒学失败的影响——越南一项整群随机对照试验
BMC Infect Dis. 2016 Dec 16;16(1):759. doi: 10.1186/s12879-016-2017-x.
9
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.齐多夫定加拉米夫定对感染个体血浆HIV水平/CD4淋巴细胞计数的影响与临床疾病发生率之间的相关性。北美拉米夫定HIV工作组。
AIDS. 1997 Feb;11(2):169-75. doi: 10.1097/00002030-199702000-00006.
10
Induction with abacavir/lamivudine/zidovudine plus efavirenz for 48 weeks followed by 48-week maintenance with abacavir/lamivudine/zidovudine alone in antiretroviral-naive HIV-1-infected patients.在未接受过抗逆转录病毒治疗的HIV-1感染患者中,使用阿巴卡韦/拉米夫定/齐多夫定加依非韦伦诱导治疗48周,随后单独使用阿巴卡韦/拉米夫定/齐多夫定进行48周的维持治疗。
J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):257-64. doi: 10.1097/01.qai.0000169664.15536.20.

引用本文的文献

1
Virological failure and associated factors among patients receiving anti-retroviral therapy in Ethiopia: A systematic review and meta-analysis.在埃塞俄比亚接受抗逆转录病毒治疗的患者中病毒学失败及相关因素的系统评价和荟萃分析。
BMJ Open. 2024 Nov 28;14(11):e087569. doi: 10.1136/bmjopen-2024-087569.
2
Immunovirological discordance among people living with human immunodeficiency virus at a center in Western India: A retrospective study.印度西部某中心人类免疫缺陷病毒感染者的免疫病毒学不一致性:一项回顾性研究。
Indian J Sex Transm Dis AIDS. 2023 Jan-Jun;44(1):15-19. doi: 10.4103/ijstd.ijstd_121_22. Epub 2023 Jun 6.
3
Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020/2021: A cross-sectional study.
2020/2021年埃塞俄比亚西北部德尔吉初级医院接受高效抗逆转录病毒治疗的HIV阳性患者的免疫病毒学状况及其相关因素:一项横断面研究
Heliyon. 2022 Aug 9;8(8):e10169. doi: 10.1016/j.heliyon.2022.e10169. eCollection 2022 Aug.
4
Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection.慢性HIV-1感染者T细胞的全球转录组特征分析
Cell Discov. 2022 Mar 28;8(1):29. doi: 10.1038/s41421-021-00367-x.
5
Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort study.社区层面的物质剥夺与加拿大观察性队列(CANOC)中联合抗逆转录病毒治疗的反应:一项纵向队列研究。
CMAJ Open. 2022 Mar 15;10(1):E183-E189. doi: 10.9778/cmajo.20200249. Print 2022 Jan-Mar.
6
Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso.布基纳法索开始抗逆转录病毒疗法的女性性工作者中的免疫病毒学不一致性。
BMC Infect Dis. 2022 Feb 3;22(1):117. doi: 10.1186/s12879-022-07109-8.
7
Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.埃塞俄比亚北部提格雷地区接受高效抗逆转录病毒治疗的艾滋病毒感染者的免疫和病毒学不一致情况。
BMC Infect Dis. 2021 Jun 12;21(1):561. doi: 10.1186/s12879-021-06206-4.
8
Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.HAART 治疗失败的病毒学和免疫学指标及相关危险因素:来自埃塞俄比亚北部提格雷地区的成年人和青少年队列研究
PLoS One. 2018 May 1;13(5):e0196259. doi: 10.1371/journal.pone.0196259. eCollection 2018.
9
Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography-electrospray ionization-tandem mass spectrometry.采用液相色谱-电喷雾电离-串联质谱法同时测定人发中的抗逆转录病毒药物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:209-221. doi: 10.1016/j.jchromb.2018.03.021. Epub 2018 Mar 11.
10
Add-on Pyridostigmine Enhances CD4 T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study.附加使用吡啶斯的明可增强HIV-1感染的免疫无应答者的CD4 T细胞恢复:一项概念验证研究。
Front Immunol. 2017 Oct 18;8:1301. doi: 10.3389/fimmu.2017.01301. eCollection 2017.